Optimization and application of a fluorimetric assay for the identification of histone deacetylase inhibitors from plant origin

References

• Basaran AA, Calis I, Anklin C, Nishibe S, Sticher O. (1988) Lavandulifolioside. A new phenylpropanoid glycoside from Stachys lavandulifolia. Helv Chim Acta, 71, 1483–1490.
   Web of Science ®Google Scholar
• Blaschek W, Frohne D, Loew D. (2009) Ratanhiae radix. In: Wichtl M, ed. Teedrogen und Phytopharmaka. 5th edition. Stuttgart: Wiss Verlags GmbH, 550–551.
   Google Scholar
• Bolden JE, Peart MJ, Johnstone RW. (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov, 5, 769–784.
   PubMed Web of Science ®Google Scholar
• Bontempo P, Mita L, Miceli M, Doto A, Nebbioso A, De Bellis F, Conte M, Minichiello A, Manzo F, Carafa V, Basile A, Rigano D, Sorbo S, Castaldo Cobianchi R, Schiavone EM, Ferrara F, De Simone M, Vietri M, Cioffi M, Sica V, Bresciani F, de Lera AR, Altucci L, Molinari AM. (2007). Feijoa sellowiana derived natural flavone exerts anti-cancer action displaying HDAC inhibitory activities. Int J Biochem Cell Biol, 39, 1902–1914.
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• Carew JS, Giles FJ, Nawrocki ST. (2008). Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy. Cancer Lett, 269, 7–17.
   PubMed Web of Science ®Google Scholar
• Chen IH, Lu MC, Du YC, Yen MH, Wu CC, Chen YH, Hung CS, Chen SL, Chang FR, Wu YC. (2009). Cytotoxic triterpenoids from the stems of Microtropis japonica. J Nat Prod, 72, 1231–1236.
   PubMed Web of Science ®Google Scholar
• Chung IM, Kim MY, Park WH, Moon HI. (2008). Histone deacetylase inhibitors from the rhizomes of Zingiber zerumbet. Pharmazie, 63, 774–776.
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Marks PA. (2005). Prospects: Histone deacetylase inhibitors. J Cell Biochem, 96, 293–304.
   PubMed Web of Science ®Google Scholar
• Frew AJ, Johnstone RW, Bolden JE. (2009). Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett, 280, 125–133.
   PubMed Web of Science ®Google Scholar
• Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA, Gruber PJ. (2008). Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. Faseb J, 22, 3549–3560.
   PubMed Web of Science ®Google Scholar
• Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature, 459, 55–60.
   PubMed Web of Science ®Google Scholar
• Hiller K, Loew D. (2009) Leonuri cardiacae herba. In: Wichtl M, ed. Teedrogen und Phytopharmaka. 5th edition. Stuttgart: Wiss Verlags GmbH, 384–385.
   Google Scholar
• Kim MJ, Ahn K, Park SH, Kang HJ, Jang BG, Oh SJ, Oh SM, Jeong YJ, Heo JI, Suh JG, Lim SS, Ko YJ, Huh SO, Kim SC, Park JB, Kim J, Kim JI, Jo SA, Lee JY. (2009). SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a. FEBS Lett, 583, 1183–1188.
   PubMed Web of Science ®Google Scholar
• Marks PA, Xu WS. (2009). Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem, 107, 600–608.
   PubMed Web of Science ®Google Scholar
• Mazitschek R, Patel V, Wirth DF, Clardy J. (2008). Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. Bioorg Med Chem Lett, 18, 2809–2812.
   PubMed Web of Science ®Google Scholar
• Newkirk TL, Bowers AA, Williams RM. (2009). Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors. Nat Prod Rep, 26, 1293–1320.
   PubMed Web of Science ®Google Scholar
• Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr. (2007). Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett, 581, 1317–1322.
   Google Scholar
• Oka S, Ago T, Kitazono T, Zablocki D, Sadoshima J. (2009). The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. J Mol Med, 87, 785–791.
   PubMed Web of Science ®Google Scholar
• Olson EN, Schneider MD. (2003). Sizing up the heart: Development redux in disease. Genes Dev, 17, 1937–1956.
   PubMed Web of Science ®Google Scholar
• Ropero S, Esteller M. (2007). The role of histone deacetylases (HDACs) in human cancer. Mol Oncol, 1, 19–25.
   PubMed Web of Science ®Google Scholar
• Smith KT, Workman JL. (2009). Histone deacetylase inhibitors: Anticancer compounds. Int J Biochem Cell Biol, 41, 21–25.
   PubMed Web of Science ®Google Scholar
• Saukel J, Gerlach S, Kubelka W. (2006) Pflanzen in der österreichischen Volksmedizin. Die„VOLKSMED-Datenbank”. Sci Pharm, 74, S 36.
   Google Scholar
• Son IH, Lee SI, Yang HD, Moon HI. (2007). bis(4-Hydroxybenzyl)sulfide: A sulfur compound inhibitor of histone deacetylase isolated from root extract of Pleuropterus ciliinervis. Molecules, 12, 815–820.
   PubMed Web of Science ®Google Scholar
• Stefanko DP, Barrett RM, Ly AR, Reolon GK, Wood MA. (2009). Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci USA, 106, 9447–9452.
   PubMed Web of Science ®Google Scholar
• Wall ME, Wani MC, Brown DM, Fullas F, Olwald JB, Josephson FF, Thorton NM, Pezzuto JM, Beecher WW, Farnsworth NR, Cordell GA, Kinghorn AD. (1996). Effects of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine, 3, 281–285.
   PubMed Web of Science ®Google Scholar
• Wegener D, Hildmann C, Riester D, Schwienhorst A. (2003). Improved fluorogenic histone deacetylase assay for high-throughput-screening applications. Anal Biochem, 321, 202–208.
   PubMed Web of Science ®Google Scholar
• Witt O, Deubzer HE, Milde T, Oehme I. (2009). HDAC family: What are the cancer relevant targets? Cancer Lett, 277, 8–21.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang H, Xu W. (2009). Strategies in developing promising histone deacetylase inhibitors. Med Research Reviews, 4, 1–16.
   Google Scholar